Skip to content
Home/Companies/HealthTech/Babyscripts
Babyscripts

Babyscripts

HealthTech·US·Active·9yr hold
Entry
2017
Hold
9yr
Status
Active

Who owns Babyscripts?

Babyscripts is currently owned by Ysios Capital Partners through Ysios BioFund II Innvierte (2016 vintage), since 2017.

Hand-verified · updated 2026-08-03

Ysios Capital Partners
Investor
Ysios Capital Partners
Ysios BioFund II Innvierte · 2016 · Life Sciences VC

Key facts

HQUS
SectorHealthTech
StatusActive
Websitebabyscripts.com

More from Ysios BioFund II Innvierte

Other portfolio companies in the same fund.

Anaconda Biomed
Anaconda Biomed
Active
MedTechES· 2017
Prexton Therapeutics
Exited 2018
BiotechCH· 2017
to
Vivet Therapeutics
Vivet Therapeutics
Active
BiotechFR· 2017
Xeltis
Xeltis
Active
MedTechNL· 2017
AELIX Therapeutics
AELIX Therapeutics
Active
BiotechES· 2016
CorWave
CorWave
Active
MedTechFR· 2016

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Paladin
Paladin
Active
Ring CapitalFrance
Access Infinity
Active
CBPE CapitalUK· 2026
Auryx
Active
VentoUnited Kingdom· 2026
Axomove
Axomove
Active
INCO VENTURESFrance· 2026
Track Babyscripts

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Babyscripts.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue